WVE - Wave Life Sciences GAAP EPS of -$0.20 beats by $0.13 revenue of $22.1M beats by $14.16M
2023-08-03 08:03:45 ET
- Wave Life Sciences press release ( NASDAQ: WVE ): Q2 GAAP EPS of -$0.20 beats by $0.13 .
- Revenue of $22.1M (+5873.0% Y/Y) beats by $14.16M .
- Shares +2% PM.
- Cash and cash equivalents of $173.0 million as of June 30, 2023, with runway expected into 2025, plus additional potential milestone payments from GSK collaboration in 2023 and beyond
For further details see:
Wave Life Sciences GAAP EPS of -$0.20 beats by $0.13, revenue of $22.1M beats by $14.16M